Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:40 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 2,294 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Coronary Artery Bypass Graft Surgery Patients
Interventions: Mean arterial pressure during cardiopulmonary bypass 80 mmHg vs. customized; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 35 Years to 89 Years
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Disease
Interventions: Fasting First, Fed First; Behavioral
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Coronary Artery Disease
Interventions: PTCA Balloon Angioplasty; Device
Lead sponsor: TriReme Medical, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 4
States / cities: Elk Grove Village, Illinois • St Louis, Missouri • York, Pennsylvania + 1 more

Conditions: Cardiac Disease, Heart Failure, Coronary Artery Disease
Interventions: CanGaroo Envelope, TYRX Envelope; Device
Lead sponsor: Elutia Inc.; Industry
Eligibility: Not listed
Enrollment: 597 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Mixed Dyslipidemia, Coronary Heart Disease, Dyslipidemia
Interventions: ABT-335, Atorvastatin, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years and older
Enrollment: 613 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: North Chicago, Illinois

Conditions: Surgery, Coronary Artery Disease
Interventions: Rocuronium, Neostigmine, Glycopyrrolate, Sugammadex; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Myocardial Infarction
Interventions: Prochymal®, Placebo; Drug
Lead sponsor: Mesoblast, Inc.; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 32
States / cities: Gilbert, Arizona • Tucson, Arizona • Sacramento, California + 29 more

Conditions: Coronary Artery Disease
Interventions: Clopidogrel, Prasugrel, ticagrelor, aspirin, rivaroxaban; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Myocardial Infarction
Interventions: Ellipsis Health Voice Application; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Myocardial Infarction, Ischemic Heart Disease
Interventions: Half-dose of the Tc99-m sestamibi (Cardiolite); Drug
Lead sponsor: Edwin Wu; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease
Interventions: Percutaneous Coronary Intervention (PCI) with Dynamic Coronary Roadmap, Percutaneous Coronary Intervention (PCI) without Dynamic Coronary Roadmap; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Denver, Colorado • New York, New York

Conditions: Smoking Cessation, Acute Coronary Syndrome
Interventions: Behavioral Activation (BA), Standard Smoking Cessation Counseling, Nicotine patch, Printed Self-help materials for Smoking Cessation; Behavioral · Drug · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: ST Elevation Myocardial Infarction
Interventions: MGuard Prime, (BMS/DES); Device
Lead sponsor: InspireMD; Industry
Eligibility: 18 Years and older
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 20
States / cities: New Haven, Connecticut • Tampa, Florida • Elk Grove Village, Illinois + 17 more

Conditions: Coronary Artery Disease, Coronary Disease, Myocardial Ischemia, Heart Diseases, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases
Interventions: CorPath robotic-assisted PCI; Device
Lead sponsor: Siemens Healthineers Endovascular Robotics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Gainesville, Georgia • Boston, Massachusetts + 5 more

Conditions: Cardiomyopathy
Interventions: Ranolazine; Drug
Lead sponsor: Cardiovascular Institute of the South Clinical Research Corporation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Lafayette, Louisiana

Conditions: Myocardial Infarction
Interventions: Provacel, Placebo; Biological
Lead sponsor: Mesoblast, Inc.; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 15
States / cities: Phoenix, Arizona • San Diego, California • Washington D.C., District of Columbia + 12 more

Conditions: Peripheral Arterial Disease, Angina
Interventions: Ranolazine, Placebo; Drug
Lead sponsor: Colorado Prevention Center; Other
Eligibility: 40 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Coronary Occlusion
Interventions: NovaCross; Device
Lead sponsor: Nitiloop Ltd.; Industry
Eligibility: 25 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Little Rock, Arkansas • New York, New York • York, Pennsylvania

Conditions: Acute Coronary Syndrome (ACS), Myocardial Infarction
Interventions: Telehealth-enhanced Hybrid CR, Traditional Cardiac Rehabilitation; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Coronary Syndrome, Heart Failure
Interventions: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 862 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts • Nashville, Tennessee

Conditions: Myocardial Infarction
Interventions: Not listed
Lead sponsor: Radiometer Medical ApS; Industry
Eligibility: 21 Years and older
Enrollment: 1,743 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 8
States / cities: Scottsdale, Arizona • Chicago, Illinois • Muncie, Indiana + 4 more

Conditions: Ischemic Heart Disease, Non-ischemic Cardiomyopathy
Interventions: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Placebo; Biological · Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Coronary Artery Disease (CAD)
Interventions: Regadenoson, Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI); Drug · Procedure
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 60
States / cities: Mobile, Alabama • Fremont, California • Long Beach, California + 52 more

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Improving Outcomes and Quality of Life After CABG

Expression of Longevity Genes in Response to Extended Fasting

An Assessment of the Glider Balloon in Complex Lesions

Retrospective Experience Of CIED Implantation

Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation

Half-Dose Radiopharmaceutical in Wide Beam Reconstruction

Dynamic Coronary Roadmap for Contrast Reduction

Post Acute Coronary Event Smoking Study

MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction

Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)

Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction

Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

Cohort B of the Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter

TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

Clinical Performance Evaluation of AQT90 FLEX TnI and TnT

Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device

A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)

Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease